Gender-specific variation in the prognosis of papillary thyroid cancer TNM stages II to IV

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Hsieh, Sheng Hwu ^a   Chen, Szu Tah ^a   Hsueh, Chuen ^a   Chao, Tzu Chieh ^a   Lin, Jen Der ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RECURRENCE RISK; SEX DIFFERENCE; THYROID CANCER; THYROIDECTOMY; TUMOR VOLUME;

EID: 84871374116     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/379097     Document Type: Article

References (26)

1. Brassard M., Borget I., Edet-Sanson A., Giraudet A. L., Mundler O., Toubeau M., Bonichon F., Borson-Chazot F., Leenhardt L., Schvartz C., Dejax C., Brenot-Rossi I., Toubert M. E., Torlontano M., Benhamou E., Schlumberger M., Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. Journal of Clinical Endocrinology and Metabolism 2011 96 5 1352 1359 2-s2.0-79955675264 10.1210/jc.2010-2708
2. Machens A., Hauptmann S., Dralle H., Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clinical Endocrinology 2006 65 4 500 505 2-s2.0-33748782764 10.1111/j.1365-2265.2006. 02623.x (Pubitemid 44414274)
3. Kushchayeva Y., Duh Q. Y., Kebebew E., D'Avanzo A., Clark O. H., Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. American Journal of Surgery 2008 195 4 457 462 2-s2.0-40949154349 10.1016/j.amjsurg.2007.06.001 (Pubitemid 351417467)
4. Ricarte-Filho J., Ganly I., Rivera M., Katabi N., Fu W., Shaha A., Tuttle R. M., Fagin J. A., Ghossein R., Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid 2012 22 6 575 584 2-s2.0-84861988936 10.1089/thy.2011.0431
5. Nishida T., Nakao K., Hashimoto T., Local control in differentiated thyroid carcinoma with extrathyroidal invasion. American Journal of Surgery 2000 179 2 86 91 2-s2.0-0034072527 10.1016/S0002-9610(00)00275-0 (Pubitemid 30204506)
6. Toniato A., Boschin I., Casara D., Mazzarotto R., Rubello D., Pelizzo M., Papillary thyroid carcinoma: factors influencing recurrence and survival. Annals of Surgical Oncology 2008 15 5 1518 1522 2-s2.0-41549162818 10.1245/s10434-008-9859-4
7. Senyurek Giles Y., Fatih T., Harika B., Yersu K., Tarik T., Serdar T., The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma. Surgery 2008 144 6 1028 1037 2-s2.0-56449100724 10.1016/j.surg.2008.08.022
8. Ghossein R. A., Leboeuf R., Patel K. N., Rivera M., Katabi N., Carlson D. L., Tallini G., Shaha A., Singh B., Tuttle R. M., Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid 2007 17 7 655 661 2-s2.0-34548185613 10.1089/thy.2007.0061 (Pubitemid 47311555)
9. Delellis R. A., Lloyd R. V., Heitx P. U., Eng C., Pathology and genetics of tumors of endocrine organs. World Health Organization of Tumours 2004 Lyon, France IARC 73 76
10. Lin J. D., Lin K. J., Chao T. C., Hseuh C., Tsang N. M., Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0. Radiotherapy and Oncology 2008 89 1 97 104 2-s2.0-54849192000 10.1016/j.radonc.2008.05.011
11. Sobin L. H., Wittekind C., TNM Classification of Malignant Tumorsedition 2002 6th New York, NY, USA Wiley-Liss
12. Zhang D. D., Zhou X. H., Freeman D. H., Freeman J. L., A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Statistics in Medicine 2002 21 5 701 715 2-s2.0-0037088346 10.1002/sim.1011 (Pubitemid 34467243)
13. De La Chapelle A., Jazdzewski K., MicroRNAs in thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2011 96 11 3326 3336 2-s2.0-80055060336 10.1210/jc.2011-1004
14. Zeng Q., Chen G. G., Vlantis A. C., Tse G. M., Van Hasselt C. A., The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. Journal of Pathology 2008 214 4 425 433 2-s2.0-40449099300 10.1002/path.2297 (Pubitemid 351350536)
15. Zhang L., Rahbari R., He M., Kebebew E., CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer. Endocrine-Related Cancer 2011 18 6 731 742 2-s2.0-84862928485 10.1530/ERC-11-0181
16. Frates M. C., Benson C. B., Doubilet P. M., Kunreuther E., Contreras M., Cibas E. S., Orcutt J., Moore F. D., Larsen P. R., Marqusee E., Alexander E. K., Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. Journal of Clinical Endocrinology and Metabolism 2006 91 9 3411 3417 2-s2.0-33748743372 10.1210/jc.2006-0690 (Pubitemid 44402112)
17. Morganti S., Ceda G. P., Saccani M., Milli B., Ugolotti D., Prampolini R., Maggio M., Valenti G., Ceresini G., Thyroid disease in the elderly: sex-related differences in clinical expression. Journal of Endocrinological Investigation 2005 28 11 101 104 2-s2.0-33746849861
18. Lin J. D., Hsieh S. H., Chang H. Y., Huang C. C., Chao T. C., Outcome after treatment for papillary thyroid cancer. Head and Neck 2001 23 2 140 146 2-s2.0-34447622455 10.1002/1097-0347(200102)23:2<140::AID-HED1009>3.0. CO;2-H
19. Jukkola A., Bloigu R., Ebeling T., Salmela P., Blanco G., Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocrine-Related Cancer 2004 11 3 571 579 2-s2.0-4944255649 10.1677/erc.1.00826 (Pubitemid 39331285)
20. Teixeira G., Teixeira T., Gubert F., Chikota H., Tufano R., The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery 2011 150 6 1161 1167 2-s2.0-82755186208 10.1016/j.surg.2011.09.019
21. Lee Y. S., Lim Y. S., Lee J. C., Wang S. G., Kim I. J., Son S. M., Lee B. J., Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Annals of Surgical Oncology 2011 18 12 3486 3492 2-s2.0-79955566399 10.1245/s10434-011- 1763-7
22. Balasubramanian S. P., Harrison B. J., Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. British Journal of Surgery 2011 98 3 334 344 2-s2.0-79151475339 10.1002/bjs.7425
23. Cooper D. S., Doherty G. M., Haugen B. R., Kloos R. T., Lee S. L., Mandel S. J., Mazzaferri E. L., McIver B., Pacini F., Schlumberger M., Sherman S. I., Steward D. L., Tuttle R. M., Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 11 1167 1214 2-s2.0-70449370231 10.1089/thy.2009.0110
24. Pacini F., Schlumberger M., Dralle H., Elisei R., Smit J. W. A., Wiersinga W., Moreno-Reyes R., Van den Bruel A., Zira C., Feldt-Rasmussen U., Godballe C., Corone C., Borson-Charzot F., Reiners C., Alevizaki M., Duntas L., Vlassopoulou B., Esik O., Mezosi E., Moriarty M. J., Smyth P., Cohen O., Krausz Y., Pellegriti G., Castagna M. G., Marga M., Bioro T., Jarzab B., Carrilho F., de Castro J. J., Limbert E. S., Ioachim D., Mogos V., Ursu H., Roumiantsev P., Troshina E., Hnilica P., Besic N., Zagar I., Gomez J. M., Sanchez-Franco F., Berg G., Tennvall J., Wallin G. K., Meier C. A., Links T. P., Ayvaz G., Uysal A. R., Cherenko S., Larin O., Harmer C., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 2006 154 6 787 803 2-s2.0-33747717014 10.1530/eje.1.02158 (Pubitemid 43997716)
25. Machens A., Holzhausen H. J., Lautenschläger C., Dralle H., The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors. Langenbeck's Archives of Surgery 2004 389 4 278 282 2-s2.0-4344639007 (Pubitemid 39128540)
26. Lin J. D., Chao T. C., Hsueh C., Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clinical Endocrinology 2007 66 2 224 228 2-s2.0-33846194586 10.1111/j.1365-2265.2006.02712.x (Pubitemid 46096142)